The scientist’s investigation covers issues in Immunology, Internal medicine, Acquired immunodeficiency syndrome, Viral load and Virology. The study incorporates disciplines such as Cytotoxic T cell, Epidemiology and Cause of death in addition to Immunology. His studies deal with areas such as Gastroenterology and Surgery as well as Internal medicine.
His Acquired immunodeficiency syndrome research includes elements of Viral disease, Cohort study, Hepatitis and Confidence interval. He has researched Viral load in several fields, including Protease inhibitor, Immunogenicity, Pharmacotherapy, Survival analysis and Risk factor. His Virology research is multidisciplinary, incorporating elements of Interferon gamma, Antibody, Molecular epidemiology and Antigen.
His primary scientific interests are in Internal medicine, Immunology, Acquired immunodeficiency syndrome, Viral load and Virology. The Internal medicine study combines topics in areas such as Gastroenterology and Surgery. Immunology and Cart are two areas of study in which he engages in interdisciplinary research.
His Acquired immunodeficiency syndrome research incorporates themes from Viral disease, Epidemiology, Cohort study and Pediatrics. Efavirenz is closely connected to Regimen in his research, which is encompassed under the umbrella topic of Viral load. His work carried out in the field of Virology brings together such families of science as Protease inhibitor, Drug resistance and Genotype.
Internal medicine, Cohort, Viral load, Confidence interval and Incidence are his primary areas of study. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Oncology. His study in Cohort is interdisciplinary in nature, drawing from both Schizophrenia, Cohort study, Hepatitis C virus, Proportional hazards model and Severity of illness.
His research in Viral load intersects with topics in Cumulative incidence, Acquired immunodeficiency syndrome, Pediatrics and Confounding. His Acquired immunodeficiency syndrome study integrates concerns from other disciplines, such as Observational study, Epidemiology, Poisson regression, Pharmacotherapy and Disease. Lymphoma is the subject of his research, which falls under Immunology.
His primary areas of investigation include Internal medicine, Cohort, Viral load, Pediatrics and Observational study. His work deals with themes such as Gastroenterology and Hiv infected, which intersect with Internal medicine. His Viral load research is multidisciplinary, relying on both Confidence interval, Hazard ratio, Acquired immunodeficiency syndrome and Confounding.
His Hazard ratio study which covers Prospective cohort study that intersects with Survival analysis. The various areas that Dominique Costagliola examines in his Acquired immunodeficiency syndrome study include Absolute risk reduction, Leverage, Virology, Regimen and Continuum of care. The concepts of his Pediatrics study are interwoven with issues in Relative risk, Randomized controlled trial and Antiretroviral treatment.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips.
The Lancet (2002)
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
Jonathan A C Sterne;Margaret May;Dominique Costagliola;Frank de Wolf.
The Lancet (2009)
Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study.
Asier Sáez-Cirión;Charline Bacchus;Laurent Hocqueloux;Véronique Avettand-Fenoel.
PLOS Pathogens (2013)
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover
Jorge R. Almeida;David A. Price;David A. Price;Laura Papagno;Zaïna Aït Arkoub.
Journal of Experimental Medicine (2007)
Causes of death in HIV-1 infected patients treated with antiretroviral therapy 1996-2006: collaborative analysis of 13 HIV cohort studies
J Gill;Margaret T May;C Lewden;M Saag.
Clinical Infectious Diseases (2010)
Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.
Murielle Mary-Krause;Laurent Cotte;Anne Simon;Maria Partisani.
Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study
Marguerite Guiguet;François Boué;Jacques Cadranel;Jean-Marie Lang.
Lancet Oncology (2009)
Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management
Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö.
The Journal of Infectious Diseases (2005)
Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.
Sophie Grabar;Vincent Le Moing;Cécile Goujard;Catherine Leport.
Annals of Internal Medicine (2000)
Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS
Charlotte Lewden;Dominique Salmon;Philippe Morlat;Sibylle Bévilacqua.
International Journal of Epidemiology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: